Pyxis Oncology Inc (PYXS)

Pyxis Oncology Inc (PYXS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $220M; returns 1 day -1.8%, 1 week +0.0%, 1 year -50.3%.

Pyxis Oncology Inc. is a clinical-stage biotechnology company primarily focused on the discovery and development of targeted oncology therapeutics.

Groups PYXS belongs to

• Biotechnology
• Oncology
• Clinical Stage Biotech
• Antibody-Drug Conjugates
• Clinical Stage
• Healthcare
• Biopharmaceutical
• Life Sciences
• Monoclonal Antibodies
• Fast Track Designation
• Strategic Pivot
• Cancer Therapeutics
• R&D

PYXS financial model: income statement, cash flow and balance sheet